Organization | Zhongshan Bo Ai Hospital

Zhongshan Bo Ai Hospital Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial

2006

NCT01784380

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2018

Timeline

NOW

Now

Alternative names

Zhongshan Bo Ai Hospital

Active Ingredients

Drugs in Phase 3 Trials (2)

platelet concentrate (1 trial)

thrombopoietin (1 trial)

Drugs in Other Trials (5)

clomifene (clomid) (1 trial)

cyproviron (1 trial)

ethinyl estradiol (Estinyl) (1 trial)

menopausal gonadotropin (1 trial)

sitagliptin (januvia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Purpura, Thrombocytopenic, Idiopathic (Phase 3)

Thrombocytopenia (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 2
# of Trial APIs: 7